CollPlant Biotechnologies recently executed a 10-for-1 reverse stock split to maintain its Nasdaq listing. We break down why companies take this drastic step and what it means for long-term shareholders.
Educational content only — not personalized financial, legal, or tax advice.
A reverse stock split is a corporate action where a company reduces the number of its outstanding shares while proportionally increasing the price of each share. For example, in a 10-for-1 split, if you owned 100 shares at $0.50, you would end up with 10 shares at $5.00. The total value of your investment remains the same, but the optics of the stock price change significantly.
Most companies, like CollPlant Biotechnologies, initiate a reverse split to meet minimum price requirements set by stock exchanges like the Nasdaq. If a stock trades below $1.00 for an extended period, it risks being delisted. Delisting can lead to lower liquidity and reduced institutional interest, which is why management often views a reverse split as a necessary evil to stay on a major exchange.
While a reverse split is a technical move, it is often a signal of underlying financial distress. It suggests that the company has been unable to generate enough organic growth or investor interest to keep its share price above the exchange's threshold. Investors should be wary of companies that use reverse splits as a 'band-aid' solution rather than addressing the core issues affecting their business performance.
Before investing in a company that has recently undergone a reverse split, look for signs of a turnaround. Is the company launching new products? Are they cutting costs? A reverse split alone does not fix a broken business model. Always prioritize companies with strong fundamentals over those that are simply trying to maintain their listing status through financial engineering.